iBionext
Sylvie Murgo is an accomplished IP Director with extensive experience in various biotechnology and pharmaceutical companies. Since 2006, Sylvie has held IP director positions at Transgene and Fovea Pharmaceuticals, subsequently serving in similar roles at GenSight Biologics, TISSIUM, BrainEver, and iBionext from 2013 to the present. Additional responsibilities include directorships at Chronolife and Tilak Healthcare until 2024, and Pixium Vision S.A. until 2024, as well as PROPHESEE until 2021. Sylvie holds a Doctor of Philosophy (PhD) in Biochemistry and Molecular Biology from Strasbourg University, complemented by further education at CEIPI.
This person is not in any teams
This person is not in any offices
iBionext
VENTURE BUILDER & GROWTH FUND Building and financing healthtech start-ups from creation to growth to transform innovation into products. OUR ACHIEVEMENTS - IBIONEXT IN NUMBERS 9 companies created 600M+ Euros raised collectively by iBionext and its companies since 2012 370+ highly qualified jobs created OUR APPROACH Spot: We provide a structural ecosystem to source, mature, finance and build innovative technologies. Boost : We gather experimented professionals to turn disruptive ideas into start-ups and lead their financing. Grow: We support the growth of our companies to maximise their value and build international champions.